Health Canada drug identification number

DIN 02543567 — ELREXFIO 76 MG

ELREXFIO is a solution of Elranatamab marketed by PFIZER CANADA ULC. The full Elranatamab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02543567
Brand name
ELREXFIO
Active ingredient
Elranatamab
Strength
76 MG
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
BCMA-directed and CD3-directed bispecific antibody (antineoplastic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Elranatamab products

DINBrandStrengthFormManufacturerStatus
02543559 ELREXFIO 44 MG SOLUTION PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.